antibiotic

(redirected from Systemic antibiotic)
Also found in: Dictionary, Medical, Legal, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for antibiotic

References in periodicals archive ?
She had undergone numerous microdebridements and several courses of drug therapy with topical and systemic antibiotics, including aminoglycosides.
23) In one recent article in which the authors described the emergence of P aeruginosa resistant to topical ciprofloxacin in CSOM, there was no mention of whether the patients had received previous systemic antibiotic therapy, and no pretreatment microbiologic data were available.
If the drainage hasn't stopped by the time they come to the office, then I switch to a systemic antibiotic.
The Company has also discovered three compounds that it has out-licensed for further development - GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which is licensed to GlaxoSmithKline; AN8194, which is licensed to Eli Lilly and Company for an animal health indication; and AN5568, which is licensed to the Drugs for Neglected Diseases initiative for sleeping sickness.
No benefit was seen when systemic antibiotic treatment was added to topical antibiotic treatment, although the evidence was limited.
Finally, there is no significant difference in effectiveness between a topical antibiotic/antiseptic alone and a combination of a topical and systemic antibiotic.
Anacor has discovered seven compounds that are currently in development including its lead compounds: tavaborole, a topical antifungal for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for the treatment of atopic dermatitis and psoriasis; GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which is licensed to GlaxoSmithKline; AN8194, which is licensed to Eli Lilly and Company for an undisclosed animal health application; and AN5568, which is licensed to Drugs for Neglected Diseases initiative for sleeping sickness.
Food and Drug Administration (FDA) favor the opposite paradigm for systemic antibiotic treatment in the Western world.
A systemic antibiotic may be used, but it's also reasonable to consider a topical antibiotic or no antibiotic at all.
Anacor has discovered seven compounds that are currently in development including its lead compounds: tavaborole, a topical antifungal for the treatment of onychomycosis; AN2728 a topical anti-inflammatory PDE-4 inhibitor for the treatment of atopic dermatitis and psoriasis; GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which is licensed to GlaxoSmithKline under the companies' research and development agreement; AN8194, which is licensed to Eli Lilly and Company for an undisclosed animal health application; and AN5568, which is licensed to Drugs for Neglected Diseases initiative for sleeping sickness.
The analysis found that in the presence of concomitant systemic antibiotic therapy, which is the use of antibiotics to treat concurrent infections, DIFICID achieved a significantly higher initial clinical cure rate, and higher rate of global cure, compared to oral vancomycin.
Anacor has discovered six compounds that are currently in development including its lead compounds: tavaborole, a topical antifungal for the treatment of onychomycosis; AN2728 a topical anti-inflammatory PDE-4 inhibitor for the treatment of atopic dermatitis and psoriasis; GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which has been licensed to GlaxoSmithKline under the companies' research and development agreement; and AN8194 which has been licensed to Eli Lilly and Company for an undisclosed animal health application.
In the planned phase 3 randomized, placebo-controlled, double-blind clinical trial, patients with a moderate or severe diabetic foot infection will be treated with Cogenzia on a daily basis as an adjunct to standard-of-care, which includes systemic antibiotic therapy administered by the oral or intravenous route.
Once the diagnosis of actinomycosis otomastoiditis has been made, the infection should be treated in the same way one would treat a typical cervicofacial Actinomyces infection, with surgical debridement and a prolonged course of a systemic antibiotic.
is indicated as an adjunct to systemic antibiotic therapy for the treatment of localized, deep tissue infections and the prevention of surgical site infections in both hard and soft tissues.
Full browser ?